// App-Quantinova.ai

: Differences in Prognosis for Patients with Interstitial Pneumonia with Acute Exacerbation of Varying Etiologies

Researchers

Presenter

  • M. Kato

Principal Investigators

  • T. Yamada

  • T. Nakamura

  • K. Kurokawa

  • Y. Ochi

  • H. Ihara

  • F. Takahashi

  • K. Takahashi

Medical Centers

  • Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic interstitial pneumonias

  • Idiopathic pulmonary fibrosis

  • Pulmonary fibrosis

  • Renal insufficiency

  • Dyspnea

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Thrombomodulin alfa

  • Polymyxin B

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved